Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-139357
Filing Date
2016-08-12
Accepted
2016-08-12 16:30:54
Documents
1
Period of Report
2016-08-11

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3959
  Complete submission text file 0001104659-16-139357.txt   5431
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4 CHARLBURY ROAD OXFORD X0 OX2 6UT
Business Address
Laing Ian Michael (Reporting) CIK: 0001661790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 161828629